Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human serum albumin (HSA) is the most abundant protein in human plasma, and its Cysteine-34 (Cys34) residue is the only free thiol group among its 35 cysteine residues (UniProt P02768). This specific residue serves as the primary extracellular antioxidant, accounting for approximately 80% of the thiol-based radical scavenging capacity in the blood (PubMed: 18482394). Under physiological conditions, Cys34 exists mostly in a reduced state known as human mercaptalbumin (HMA), but it is susceptible to oxidation to human non-mercaptalbumin (HNA) during systemic inflammation or oxidative stress (PubMed: 25503335). Beyond its redox role, Cys34 is a key site for the covalent attachment of drugs, particularly those designed for long-circulating prodrug delivery systems like Aldoxorubicin (PubMed: 24138310). It also interacts with metal-based therapeutics such as cisplatin and gold-based drugs, significantly influencing the pharmacokinetics and toxicity profiles of various pharmacological agents (PubMed: 22403074).
Covalent conjugation to the free thiol group, thiol-disulfide exchange, and scavenging of reactive oxygen and nitrogen species.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human serum albumin (HSA) Cysteine-34 (HSA (Cys34)).